<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>9939614</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">36814614</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">9939614</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pii">S2405-8440(23)00630-8</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.1016/j.heliyon.2023.e13423</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">e13423</article-id></all-ids><extracted-table><table-id>tbl1</table-id><table-label>Table 1</table-label><table-caption>Demographic and clinical data of patients with CHD and HCs.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="tbl1"><label>Table 1</label><caption><p>Demographic and clinical data of patients with CHD and HCs.</p></caption><alt-text id="alttext0015">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th/><th>CHD (n = 26)</th><th>HCs (n = 16)</th><th>t/z/χ</th><th>Effect size</th><th><italic>p</italic> value</th></tr></thead><tbody><tr><td align="left">Age (year)</td><td align="left">60.46 ± 8.85</td><td align="left">57.25 ± 10.48</td><td align="left">1.064</td><td align="left">0.338<sup>a</sup></td><td align="left">0.294<sup>c</sup></td></tr><tr><td align="left">Sex (male/female)</td><td align="left">13/13</td><td align="left">5/11</td><td align="left">1.422</td><td align="left">0.184<sup>b</sup></td><td align="left">0.233</td></tr><tr><td align="left">BMI</td><td align="left">24.25 ± 3.01</td><td align="left">24.94 ± 3.93</td><td align="left">−0.181</td><td align="left">0.205<sup>a</sup></td><td align="left">0.856<sup>d</sup></td></tr><tr><td align="left">Hypertension classification (Normal/Grade I/II/III)</td><td align="left">10/9/5/2</td><td align="left">9/5/2/0</td><td align="left">1.852</td><td align="left">0.220<sup>b</sup></td><td align="left">0.699</td></tr><tr><td align="left">Total cholesterol (mmol/L)</td><td align="left">4.40 ± 1.12</td><td align="left">3.86 ± 0.90</td><td align="left">1.653</td><td align="left">0.525<sup>a</sup></td><td align="left">0.106<sup>c</sup></td></tr><tr><td align="left">Triglycerides (mmol/L)</td><td align="left">1.94 ± 1.14</td><td align="left">1.49 ± 0.68</td><td align="left">−0.933</td><td align="left">0.449<sup>a</sup></td><td align="left">0.351<sup>d</sup></td></tr><tr><td align="left">Low-density lipoproteins (mmol/L)</td><td align="left">2.62 ± 1.03</td><td align="left">2.29 ± 0.91</td><td align="left">1.063</td><td align="left">0.338<sup>a</sup></td><td align="left">0.294<sup>c</sup></td></tr><tr><td align="left">Lipoprotein (a) (mg/L)</td><td align="left">186.25 ± 200.35</td><td align="left">245.08 ± 277.41</td><td align="left">−0.195</td><td align="left">0.253<sup>a</sup></td><td align="left">0.846<sup>d</sup></td></tr><tr><td align="left">Uric acid (umol/L)</td><td align="left">335.69 ± 87.95</td><td align="left">323.75 ± 95.27</td><td align="left">0.414</td><td align="left">0.132<sup>a</sup></td><td align="left">0.681<sup>c</sup></td></tr><tr><td align="left">Ejection fraction (%)</td><td align="left">65.38 ± 4.06</td><td align="left">65.38 ± 7.07</td><td align="left">−1.040</td><td align="left">0.002<sup>a</sup></td><td align="left">0.298<sup>d</sup></td></tr></tbody></table><table-wrap-foot><fn><p>The continuous variables are expressed as the mean ± standard deviation (Mean ± SD). BMI: body mass index; CHD: coronary heart disease; HCs: healthy controls. Effect size: Cohen's d (a) and η<sup>2</sup> (b); Statistical analyses: independent-sample <italic>t</italic>-test (c) and Mann-Whitney test (d).</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic and clinical data of patients with CHD and HCs.</div>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th>CHD (n = 26)</th><th>HCs (n = 16)</th><th>t/z/χ</th><th>Effect size</th><th>p value</th></tr></thead><tbody><tr><td align="left">Age (year)</td><td align="left">60.46 ± 8.85</td><td align="left">57.25 ± 10.48</td><td align="left">1.064</td><td align="left">0.338a</td><td align="left">0.294c</td></tr><tr><td align="left">Sex (male/female)</td><td align="left">13/13</td><td align="left">5/11</td><td align="left">1.422</td><td align="left">0.184b</td><td align="left">0.233</td></tr><tr><td align="left">BMI</td><td align="left">24.25 ± 3.01</td><td align="left">24.94 ± 3.93</td><td align="left">−0.181</td><td align="left">0.205a</td><td align="left">0.856d</td></tr><tr><td align="left">Hypertension classification (Normal/Grade I/II/III)</td><td align="left">10/9/5/2</td><td align="left">9/5/2/0</td><td align="left">1.852</td><td align="left">0.220b</td><td align="left">0.699</td></tr><tr><td align="left">Total cholesterol (mmol/L)</td><td align="left">4.40 ± 1.12</td><td align="left">3.86 ± 0.90</td><td align="left">1.653</td><td align="left">0.525a</td><td align="left">0.106c</td></tr><tr><td align="left">Triglycerides (mmol/L)</td><td align="left">1.94 ± 1.14</td><td align="left">1.49 ± 0.68</td><td align="left">−0.933</td><td align="left">0.449a</td><td align="left">0.351d</td></tr><tr><td align="left">Low-density lipoproteins (mmol/L)</td><td align="left">2.62 ± 1.03</td><td align="left">2.29 ± 0.91</td><td align="left">1.063</td><td align="left">0.338a</td><td align="left">0.294c</td></tr><tr><td align="left">Lipoprotein (a) (mg/L)</td><td align="left">186.25 ± 200.35</td><td align="left">245.08 ± 277.41</td><td align="left">−0.195</td><td align="left">0.253a</td><td align="left">0.846d</td></tr><tr><td align="left">Uric acid (umol/L)</td><td align="left">335.69 ± 87.95</td><td align="left">323.75 ± 95.27</td><td align="left">0.414</td><td align="left">0.132a</td><td align="left">0.681c</td></tr><tr><td align="left">Ejection fraction (%)</td><td align="left">65.38 ± 4.06</td><td align="left">65.38 ± 7.07</td><td align="left">−1.040</td><td align="left">0.002a</td><td align="left">0.298d</td></tr></tbody></table></div>The continuous variables are expressed as the mean ± standard deviation (Mean ± SD). BMI: body mass index; CHD: coronary heart disease; HCs: healthy controls. Effect size: Cohen's d (a) and η2 (b); Statistical analyses: independent-sample t-test (c) and Mann-Whitney test (d).</transformed-table></extracted-table><extracted-table><table-id>tbl2</table-id><table-label>Table 2</table-label><table-caption>Left thalamus-based FC patterns between patients with CHD and HCs.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="tbl2"><label>Table 2</label><caption><p>Left thalamus-based FC patterns between patients with CHD and HCs.</p></caption><alt-text id="alttext0020">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Brain regions</th><th colspan="3">MNI coordinates<hr/></th><th rowspan="2">Cluster size</th><th rowspan="2">T score</th></tr><tr><th>X</th><th>Y</th><th>Z</th></tr></thead><tbody><tr><td align="left">Left supplementary motor area</td><td align="left">−6</td><td align="left">−12</td><td align="left">51</td><td align="left">25</td><td align="left">−4.1161</td></tr><tr><td align="left">Left superior frontal gyrus</td><td align="left">−9</td><td align="left">15</td><td align="left">42</td><td align="left">22</td><td align="left">−3.6615</td></tr></tbody></table><table-wrap-foot><fn><p>CHD: coronary heart disease; FC: functional connectivity; HCs: healthy controls; MNI: Montreal Neurological Institute. <italic>P</italic> &lt; 0.001, uncorrected.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Left thalamus-based FC patterns between patients with CHD and HCs.</div>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Brain regions</th><th colspan="3">MNI coordinates</th><th rowspan="2">Cluster size</th><th rowspan="2">T score</th></tr><tr><th>X</th><th>Y</th><th>Z</th></tr></thead><tbody><tr><td align="left">Left supplementary motor area</td><td align="left">−6</td><td align="left">−12</td><td align="left">51</td><td align="left">25</td><td align="left">−4.1161</td></tr><tr><td align="left">Left superior frontal gyrus</td><td align="left">−9</td><td align="left">15</td><td align="left">42</td><td align="left">22</td><td align="left">−3.6615</td></tr></tbody></table></div>CHD: coronary heart disease; FC: functional connectivity; HCs: healthy controls; MNI: Montreal Neurological Institute. P &lt; 0.001, uncorrected.</transformed-table></extracted-table><extracted-table><table-id>tbl3</table-id><table-label>Table 3</table-label><table-caption>Right thalamus-based FC patterns between patients with CHD and HCs.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="tbl3"><label>Table 3</label><caption><p>Right thalamus-based FC patterns between patients with CHD and HCs.</p></caption><alt-text id="alttext0025">Table 3</alt-text><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Brain regions</th><th colspan="3">MNI coordinates<hr/></th><th rowspan="2">Cluster size</th><th rowspan="2">T score</th></tr><tr><th>X</th><th>Y</th><th>Z</th></tr></thead><tbody><tr><td align="left">Left supplementary motor area</td><td align="left">−9</td><td align="left">−12</td><td align="left">51</td><td align="left">26</td><td align="left">−4.3674</td></tr><tr><td align="left">Left superior parietal gyrus</td><td align="left">−27</td><td align="left">−69</td><td align="left">51</td><td align="left">86</td><td align="left">−4.1766</td></tr><tr><td align="left">Left inferior parietal gyrus</td><td align="left">−42</td><td align="left">−30</td><td align="left">24</td><td align="left">30</td><td align="left">−3.6629</td></tr><tr><td align="left">Left middle cingulate cortex</td><td align="left">−9</td><td align="left">−33</td><td align="left">39</td><td align="left">29</td><td align="left">−3.8385</td></tr><tr><td align="left">Left lingual gyrus</td><td align="left">−15</td><td align="left">−81</td><td align="left">−3</td><td align="left">45</td><td align="left">−3.8120</td></tr><tr><td align="left">Left calcarine sulcus</td><td align="left">−18</td><td align="left">−72</td><td align="left">15</td><td align="left">86</td><td align="left">−3.8195</td></tr></tbody></table><table-wrap-foot><fn><p>CHD: coronary heart disease; FC: functional connectivity; HCs: healthy controls; MNI: Montreal Neurological Institute. <italic>P</italic> &lt; 0.001, uncorrected.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Right thalamus-based FC patterns between patients with CHD and HCs.</div>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Brain regions</th><th colspan="3">MNI coordinates</th><th rowspan="2">Cluster size</th><th rowspan="2">T score</th></tr><tr><th>X</th><th>Y</th><th>Z</th></tr></thead><tbody><tr><td align="left">Left supplementary motor area</td><td align="left">−9</td><td align="left">−12</td><td align="left">51</td><td align="left">26</td><td align="left">−4.3674</td></tr><tr><td align="left">Left superior parietal gyrus</td><td align="left">−27</td><td align="left">−69</td><td align="left">51</td><td align="left">86</td><td align="left">−4.1766</td></tr><tr><td align="left">Left inferior parietal gyrus</td><td align="left">−42</td><td align="left">−30</td><td align="left">24</td><td align="left">30</td><td align="left">−3.6629</td></tr><tr><td align="left">Left middle cingulate cortex</td><td align="left">−9</td><td align="left">−33</td><td align="left">39</td><td align="left">29</td><td align="left">−3.8385</td></tr><tr><td align="left">Left lingual gyrus</td><td align="left">−15</td><td align="left">−81</td><td align="left">−3</td><td align="left">45</td><td align="left">−3.8120</td></tr><tr><td align="left">Left calcarine sulcus</td><td align="left">−18</td><td align="left">−72</td><td align="left">15</td><td align="left">86</td><td align="left">−3.8195</td></tr></tbody></table></div>CHD: coronary heart disease; FC: functional connectivity; HCs: healthy controls; MNI: Montreal Neurological Institute. P &lt; 0.001, uncorrected.</transformed-table></extracted-table></extracted-tables-set>